Notice of Interim Results

RNS Number : 0032J
NetScientific PLC
06 September 2016
 

 

 

("NetScientific" or the "Company" or the "Group")

 

 

Notice of Interim Results

 

 

London, UK - 6 September 2016 - NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that it will report its interim results for the six months ended 30 June 2016 on Tuesday 27 September2016.

 

An analyst presentation will be held at the offices of Stifel Nicholaus Europe at 150 Cheapside, London EC2V 6ET at 12.00pm on Tuesday 27 September 2016.

 

- Ends -

 

 

For more information, please contact:

 

NetScientific

François R. Martelet, M.D., CEO

Ian Postlethwaite, CFO

 

Tel: +44 (0)20 3514 1800

Stifel Nicolaus Europe Limited (NOMAD and broker)

Jonathan Senior / David Arch / Ben Maddison

Tel: +44 (0)20 7710 7600

 

Consilium Strategic Communications

Mary-Jane Elliott / Chris Gardner / Jessica Hodgson / Chris Welsh / Laura Thornton

 

 

Tel: +44 (0)20 3709 5700

netscientific@consilium-comms.com

 

 

About NetScientific Plc

 

NetScientific is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases. For more information, please visit the website at www.netscientific.net.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NORAKPDKABKDDCK
UK 100

Latest directors dealings